Nephrotic Syndrome in KidsFrom March 2019, A World of (Bladder) Hurt
Jason Woods digs deep into the diagnosis, complications, and management of nephrotic syndrome with pediatric nephrology doctor Danielle Sorrano. •15min 51Danielle Sorrano, MD and Jason Woods, MD
Paper Chase #4 - PFO Closure or AC vs. Antiplatelets after CVAFrom March 2018, What’s Your (Code) Status?
Patients who had had a recent cryptogenic stroke attributed to PFO had lower stroke recurrence if assigned to PFO closure combined with antiplatelet therapy than those assigned to antiplatelet therapy alone.7min 19Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase #3 - ACE Inhibitors and Statins in Adolescents with Type 1 DiabetesFrom March 2018, What’s Your (Code) Status?
ACE inhibitors and statins did not change the albumin to creatinine ratio over time in this study population.2min 54Andrew Buelt, DO and Joe Weatherly, DO
Polycystic Kidney Disease (PKD), Part 1From January 2018, A Feverish Frenzy!
Autosomal dominant polycystic kidney disease is broken down into two main subtypes: PKD-1 and PKD-2. PKD-1 leads to renal impairment approximately 20 years before PKD-2. While there is a 50% chance that the offspring of a parent with PKD will have the condition, routine screening before the age …13min 13Neda Frayha, MD and Terry Watnick, MD
Polycystic Kidney Disease (PKD), Part 2From January 2018, A Feverish Frenzy!
Autosomal dominant polycystic kidney disease is broken down into two main subtypes: PKD-1 and PKD-2. PKD-1 leads to renal impairment approximately 20 years before PKD-2. While there is a 50% chance that the offspring of a parent with PKD will have the condition, routine screening before the age …12min 22Neda Frayha, MD and Terry Watnick, MD
Paperchase #2 - Liraglutide and Renal Outcomes in Type 2 DiabetesFrom December 2017, Jingle, Jingle
This study looks at the secondary endpoints of the LEADER trial to find the renal benefit to taking Liraglutide in type 2 diabetic patients. Compared to placebo, this GLP-1 resulted in lower rates of progression to chronic kidney disease. •5min 4Andrew Buelt, DO and Joe Weatherly, DO
The Primary Care RAP Hot Sheet: March 2017From March 2017, The Primary Care RAP Hot Sheet: March 2017
This month, Andrew and Joe suffer from some entertaining loosening of associations as they connect obscure March holidays to recent studies on flexible sigmoidoscopy, lung cancer screening, and metformin in chronic kidney disease. (Spoiler: Awkward Moment Day is an actual thing.) •5min 36Andrew Buelt, DO, Joe Weatherly, DO, and Heidi James, MD
Things I Do But Should I? Routine Urinalysis in PregnancyFrom March 2017, The Benzos & Fungus Among Us
Checking for proteinuria and glycosuria is standard of care in many institutions as a means to screen for pre-eclampsia and gestational diabetes. A review of the evidence suggests that we have other, much better screening tests (check blood pressure for pre-eclampsia and oral glucose tolerance …9min 7Vanessa Cardy, MD and Adrien Selim, MD
Paper Chase 4: Annual Testing of Chronic Kidney DiseaseFrom March 2016, Where Has All The Testosterone Gone?
Co-management of CKD3+ was associated with increased stage-appropriate monitoring and ACE/ARB prescribing, but not improved blood pressure control. •4min 57Andrew Buelt, DO and Joe Weatherly, DO
A Primer on Serum Protein Electrophoresis (SPEP)From January 2016, Palliative Cerumen Emergencies
Protein electrophoresis is one of the most commonly ordered lab tests, but what do the results mean? Hematologist Tom Deloughery reviews indications for testing and interpretation of (the sometimes confusing) results. •17min 54Tom Deloughery, MD and Rob Orman, MD
Pediatric Nephrology: ProteinuriaFrom December 2015, Mythbusting Eggs, Flu, and the CBC
Discuss workup and management of proteinuria.21min 45Kate Wesseling-Perry, MD and Solomon Behar, MD
Pediatric Nephrology: HematuriaFrom December 2015, Mythbusting Eggs, Flu, and the CBC
Discuss when hematuria is concerning and when workup is warranted.15min 22Solomon Behar, MD and Kate Wesseling-Perry, MD